tiprankstipranks
Advertisement
Advertisement

KPTI Stock Latest News

GoDaddy, NXT, Karyopharm, AXT, Enbridge Trending With Analysts
Weekend UpdatesGoDaddy, NXT, Karyopharm, AXT, Enbridge Trending With Analysts
2h ago
ENB
NXT
Karyopharm price target lowered to $11 from $14 at Jefferies
PremiumThe Fly
Karyopharm price target lowered to $11 from $14 at Jefferies
21h ago
KPTI
Karyopharm Reports Selinexor Trial Results, Explores Strategic Options
PremiumCompany Announcements
Karyopharm Reports Selinexor Trial Results, Explores Strategic Options
22h ago
8K
KPTI
Karyopharm price target lowered to $7 from $16 at Piper Sandler
PremiumThe Fly
Karyopharm price target lowered to $7 from $16 at Piper Sandler
24h ago
KPTI
Karyopharm downgraded to Neutral from Buy at H.C. Wainwright
PremiumThe Fly
Karyopharm downgraded to Neutral from Buy at H.C. Wainwright
1d ago
KPTI
Karyopharm downgraded to Neutral from Outperform at Baird
PremiumThe FlyKaryopharm downgraded to Neutral from Outperform at Baird
1d ago
KPTI
Karyopharm down 69% after XPORT-EC-042 trial did not meet primary endpoint
Premium
The Fly
Karyopharm down 69% after XPORT-EC-042 trial did not meet primary endpoint
2d ago
KPTI
Karyopharm to submit sNDA for selinexor plus ruxolitinib
Premium
The Fly
Karyopharm to submit sNDA for selinexor plus ruxolitinib
2d ago
KPTI
Karyopharm’s endometrial cancer candidate did not meet Phase 3 primary endpoint
PremiumThe Fly
Karyopharm’s endometrial cancer candidate did not meet Phase 3 primary endpoint
2d ago
KPTI
Karyopharm trading resumes
PremiumThe Fly
Karyopharm trading resumes
2d ago
KPTI
Karyopharm trading halted, news pending
PremiumThe Fly
Karyopharm trading halted, news pending
2d ago
KPTI
Is KPTI a Buy, Before Earnings?
PremiumPre-Earnings
Is KPTI a Buy, Before Earnings?
4d ago
KPTI
Karyopharm sinks after revealing executive cash retention program
PremiumThe FlyKaryopharm sinks after revealing executive cash retention program
12d ago
KPTI
RBC says Karyopharm weakness after compensation plan a buying opportunity
Premium
The Fly
RBC says Karyopharm weakness after compensation plan a buying opportunity
12d ago
KPTI
Karyopharm Launches 2026 Executive Retention Incentive Program
Premium
Company Announcements
Karyopharm Launches 2026 Executive Retention Incentive Program
14d ago
8K
KPTI
Karyopharm says Phase 3 SENTRY trial selected for presentation at EHA 2026
PremiumThe Fly
Karyopharm says Phase 3 SENTRY trial selected for presentation at EHA 2026
2M ago
KPTI
Karyopharm’s selinexor combination shows efficacy in myelofibrosis
PremiumThe Fly
Karyopharm’s selinexor combination shows efficacy in myelofibrosis
2M ago
KPTI
Karyopharm Expands Equity Incentives and Launches PSU Program
PremiumCompany Announcements
Karyopharm Expands Equity Incentives and Launches PSU Program
2M ago
8K
KPTI
Karyopharm (KPTI) Leans on SENTRY in Pivotal Call
PremiumCompany Announcements
Karyopharm (KPTI) Leans on SENTRY in Pivotal Call
2M ago
KPTI
Karyopharm Earnings Call: Trial Wins, Cash Questions
PremiumCompany AnnouncementsKaryopharm Earnings Call: Trial Wins, Cash Questions
3M ago
KPTI
Karyopharm reports Q1 EPS ($1.24), consensus ($1.44)
Premium
The Fly
Karyopharm reports Q1 EPS ($1.24), consensus ($1.44)
3M ago
KPTI
Karyopharm sees 2026 revenue $130M-$150M, consensus $137.49M
Premium
The Fly
Karyopharm sees 2026 revenue $130M-$150M, consensus $137.49M
3M ago
KPTI

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >